Quest Diagnostics Balance Sheet
DGX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Quest Diagnostics had $16.2B in total assets and $7.2B in shareholders' equity as of FY2025. Total debt was $5.7B against $420M in cash, resulting in $5.3B net debt.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420.0M | $549.0M | $686.0M | $315.0M | $872.0M | $1.2B | $1.2B | $137.0M | $359.0M | $192.0M | $187.0M | $192.0M | $165.0M | $296.0M | $165.0M |
| Accounts Receivable | $1.4B | $1.3B | $1.2B | $1.2B | $1.4B | $1.5B | $1.1B | $1.0B | $924.0M | $926.0M | $901.0M | $932.0M | $852.0M | $867.0M | $906.5M |
| Inventory | $189.0M | $188.0M | $190.0M | $192.0M | $208.0M | $223.0M | $123.0M | $99.0M | $95.0M | $82.0M | $84.0M | $110.0M | $91.0M | $93.0M | $89.1M |
| Current Assets | $2.4B | $2.4B | $2.4B | $1.9B | $2.7B | $3.1B | $2.5B | $1.4B | $1.3B | $1.5B | $1.5B | $1.6B | $1.4B | $1.6B | $1.4B |
| PP&E (Net) | $2.2B | $2.1B | $1.8B | $1.8B | $1.7B | $1.6B | $1.5B | $1.3B | $1.1B | $1.0B | $925.0M | $933.0M | $805.0M | $756.0M | $799.8M |
| Goodwill | $8.9B | $8.9B | $7.2B | $7.1B | $6.9B | $6.9B | $6.6B | $6.3B | $6.0B | $5.9B | $6.0B | $6.0B | $5.5B | $5.5B | $5.8B |
| Total Assets | $16.2B | $16.2B | $14.0B | $12.8B | $13.6B | $14.0B | $12.8B | $11.0B | $10.5B | $10.1B | $10.0B | $9.9B | $8.9B | $9.3B | $9.3B |
| Current Liabilities | $2.3B | $2.2B | $1.8B | $1.6B | $1.8B | $1.8B | $2.0B | $1.5B | $1.1B | $981.0M | $1.2B | $1.7B | $1.1B | $1.0B | $1.6B |
| Total Debt | $5.7B | $6.2B | $4.7B | $4.0B | $4.0B | $4.0B | $4.8B | $3.9B | $3.8B | $3.7B | $3.7B | $3.7B | $3.3B | $3.4B | $3.9B |
| Shareholders' Equity | $7.2B | $6.8B | $6.3B | $5.9B | $6.4B | $6.8B | $5.6B | $5.2B | $4.9B | $4.6B | $4.7B | $4.3B | $3.9B | $4.2B | $3.7B |